Fate Therapeutics Inc Revenue per Employee (FATE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Fate Therapeutics Inc   (NASDAQ: FATE)
 

Fate Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 9.18% in the second quarter 2026, year on year to cumulative value of $6 million, Fate Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 40,317. The productivity of Fate Therapeutics Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 507 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 3517, from total ranking in previous quarter at 3999. Fate Therapeutics Inc has 161 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FATE Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 9.18 % -20.26 % -26.4 % -43.36 % -71.84 %
Sales per Employee (TTM) $ 40,317 39,230 41,280 44,329 52,609
FATE's Total Ranking # 3517 # 3999 # 3669 # 3699 # 3578
Seq. Revenue Change 60.28 % -5.11 % -21.37 % -8.7 % 17.07 %

FATE Company Profile >> Back to FATE Efficiency Comparisons >> Compare FATE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 61
Healthcare Sector # 508
Overall Market # 3517

Revenue per Employee Statistics
High Average Low
$ 850,099 $ 169,507 $ -4,335
(Mar 31 2023)   (Dec 31 2013)



Financial Statements
Fate Therapeutics Inc 's Revenue MRQ $ 2 Millions Visit FATE's Income Statement
Fate Therapeutics Inc 's Revenues TTM $ 6 Millions Visit FATE's aggregate revenue growth
What are FATE's Sales? Visit FATE's Sales by Segment




Other Ratios
Fate Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
FATE's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for FATE's Competitors
Revenue per Employee for FATE's Suppliers
Revenue per Employee for FATE's Customers

You may also want to know
FATE's Sales Growth Rates FATE's Pe Price to earnings ratio FATE's Receivables Turnover Ratio FATE's Stock Quote
FATE's Net Income Growth Rates FATE's Ps Price to Sales ratio FATE's Sales per Employee FATE's Asset Turnover Ratio
FATE's Net Margin FATE's Pb Price to Book ratio FATE's Financial Strength Ratios FATE's Dividend Payout Ratio
Date modified: 2026-09-03T11:45:04+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Atrium Therapeutics Inc   70,399.22 $ 35.974  Million 511 
Onemednet Corporation  69,130.43 $ 1.590  Million 23 
Ispecimen inc   66,614.57 $ 0.466  Million 7 
Lucid Diagnostics Inc   66,402.44 $ 5.445  Million 82 
Cannapharmarx Inc   65,342.92 $ 1.699  Million 26 
Agape Atp Corporation  64,026.78 $ 1.152  Million 18 
Vistagen Therapeutics Inc   61,000.00 $ 2.501  Million 41 
Blue Water Vaccines Inc  58,711.64 $ 0.646  Million 11 
Dar Bioscience Inc   56,031.96 $ 1.345  Million 24 
Petvivo Holdings Inc   53,712.00 $ 1.182  Million 22 
Vsee Health Inc   51,479.38 $ 10.759  Million 209 
Biocorrx Inc   43,701.83 $ 0.787  Million 18 
Vyne Therapeutics Inc   43,000.00 $ 0.430  Million 10 
Femasys Inc   42,581.67 $ 2.299  Million 54 
Fate Therapeutics Inc   40,316.77 $ 6.491  Million 161 
Alumis inc   33,026.79 $ 7.398  Million 224 
Volitionrx Limited  32,773.92 $ 2.458  Million 75 
Longeveron Inc   31,236.84 $ 1.187  Million 38 
Dbv Technologies S a   29,517.65 $ 5.018  Million 170 
Addus Homecare Corp  29,128.29 $ 1,475.610  Million 50,659 
Insight Molecular Diagnostics Inc   28,793.10 $ 1.670  Million 58 
Scientific Industries Inc   28,357.43 $ 5.728  Million 202 
Bioxcel Therapeutics Inc   25,586.21 $ 0.742  Million 29 
Bioadaptives Inc   25,561.00 $ 0.026  Million 1 
Envoy Medical Inc   20,700.00 $ 0.207  Million 10 
Northwest Biotherapeutics Inc  20,695.24 $ 2.173  Million 105 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.